Comparing the tolerability of preservative-free tafluprost versus preserved latanoprost in the management of glaucoma and ocular hypertension — an observer blinded active-control trial
Crossref DOI link: https://doi.org/10.1007/s11845-024-03704-7
Published Online: 2024-05-15
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brinkman, David http://orcid.org/0000-0003-2077-6423
McSwiney, Terence
James, Mark
Text and Data Mining valid from 2024-05-15
Version of Record valid from 2024-05-15
Article History
Received: 2 December 2023
Accepted: 7 May 2024
First Online: 15 May 2024
Declarations
:
: None.